

88,943,841 shares will be reduced from the current Outstanding share count AUSTIN, TX / ACCESS Newswire / April 24, 2025 / Software Effective Solutions Corp. (OTC PINK:SFWJ), doing business as MedCana, is canceling 16,193,760 million shares and swapping 72,750,081 million shares of its Common stock. All 88,943,841 shares will show a reduction in the outstanding share count.

AUSTIN, TX / ACCESS Newswire / April 17, 2025 / Software Effective Solutions Corp. (OTC:SFWJ), doing business as Medcana, today announced it is proceeding with the acquisition of pharmaceutical cannabis licenses to import and distribute cannabis in Australia. This move marks a significant milestone in Medcana's global growth strategy.

AUSTIN, TEXAS / ACCESS Newswire / April 10, 2025 / Software Effective Solutions Corp. (OTC PINK:SFWJ), doing business as Medcana, is canceling 86,916,294 million shares of its Common stock. The shares were issued several years ago, and even though they have a legend on them, they could have entered the system at any time.

AUSTIN, TEXAS / ACCESS Newswire / April 2, 2025 / Software Effective Solutions Corp. (OTC PINK:SFWJ), doing business as Medcana, is proud to announce the successful export of its first pharmaceutical-grade CBD crop through its Colombian partner, Anutea S.A.S., marking a significant operational milestone in the company's international expansion strategy.

AUSTIN, Texas , Feb. 20, 2025 /PRNewswire/ -- MedCana (OTC: SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, is pleased to announce the successful completion of its latest CBD harvest, which significantly exceeded expectations. The company achieved more than double the anticipated yield with zero issues—no pests, no botrytis, and no setbacks of any kind.

MedCana to enter into supply Agreement worth $1.2 - $2.4 million Annually AUSTIN, Texas , Oct. 16, 2024 /PRNewswire/ -- MedCana (OTC: SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, proudly announces through one of its subsidiaries in Colombia, has entered negotiations with an Australian pharmaceutical firm to supply medical-grade cannabis. The agreement is projected to provide between $100,000 to $200,000 in monthly revenue once operations begin.

The licenses will add $1.6 million to our total Assets for the 3rd Quarter. AUSTIN, TX / ACCESSWIRE / October 9, 2024 / MedCana (OTC PINK:SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, proudly announces significant and multiple acquisitions, along with multiple cannabis licenses associated with each, bolstering the company's cannabis portfolio globally.

In the news release, MedCana Seeks Expansion into the Australian Pharmaceutical Cannabis Market Amid Projected Industry Growth, issued Oct. 3, 2024 by MedCana over PR Newswire, we are advised by the company that MedCana's stock ticker has been added to the release (OTC: SFWJ). The complete, corrected release follows: MedCana Seeks Expansion into the Australian Pharmaceutical Cannabis Market Amid Projected Industry Growth AUSTIN, Texas , Oct. 3, 2024 /PRNewswire/ -- MedCana (OTC: SFWJ), a holding company specializing in agricultural technology and the cannabis industry, is actively analyzing opportunities to enter the Australian pharmaceutical cannabis market.